This department is offering the Type 1 Diabetes in Acute Pancreatitis Consortium – Clinical Centers Grant for the establishment of a clinical consortium to conduct studies on Type 1 diabetes occurring after acute pancreatitis. The grant aims to gain insight into the incidence, clinical evolution, etiology, type, and pathophysiology of Type 1 diabetes and other forms of diabetes that occur after acute pancreatitis episodes. The consortium will focus on identifying immune and genetic risk factors and biomarkers predicting Type 1 diabetes development in a diverse population. Applications for the Data Coordinating Center are submitted separately.
Opportunity ID: 322943
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-19-022 |
| Funding Opportunity Title: | Type 1 Diabetes in Acute Pancreatitis Consortium – Clinical Centers (T1DAPC-CCs) (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 09, 2019 |
| Last Updated Date: | Dec 09, 2019 |
| Original Closing Date for Applications: | Mar 13, 2020 |
| Current Closing Date for Applications: | Mar 13, 2020 |
| Archive Date: | Apr 18, 2020 |
| Estimated Total Program Funding: | $2,700,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Small businesses County governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits U01 applications for the establishment of a clinical consortium, composed of one Data Coordinating Center (DCC) and up to 10 Clinical Centers (CC), to conduct studies on diabetes mellitus, with an emphasis on Type 1 diabetes (T1D), that occurs after or as a consequence of one or more episodes of acute pancreatitis. The Consortium will form multi-disciplinary teams composed of members from the CCs and DCC to undertake a prospective longitudinal observational study of the occurrence of diabetes that occurs during an acute pancreatitis episode or subsequently, with an emphasis on type 1 diabetes (T1D). The study will be designed to gain insight into the incidence, clinical evolution, etiology, type and pathophysiology of the T1D and other forms of diabetes that occurs during or after one or more episodes of acute pancreatitis. The teams will also undertake studies on the identification of immune and genetic risk factors and biomarkers which predict the development of T1D in a racially, ethnically, and geographically diverse population of subjects who have impaired glucose tolerance or diabetes mellitus after one or more episodes of acute pancreatitis due to various identifiable etiologies. Applications for the Data Coordinating Center (DCC) are submitted in response to a separate FOA: RFA-DK-19-023: Type 1 Diabetes in Acute Pancreatitis Consortium Data Coordinating Center (T1DAPC-DCC) (U01). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257061 | Feb 13, 2020 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259529 | Feb 13, 2020 | Mar 13, 2020 | View |
Package 1
Mandatory forms
322943 RR_SF424_2_0-2.0.pdf
322943 PHS398_CoverPageSupplement_4_0-4.0.pdf
322943 RR_OtherProjectInfo_1_4-1.4.pdf
322943 PerformanceSite_2_0-2.0.pdf
322943 RR_KeyPersonExpanded_2_0-2.0.pdf
322943 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
322943 RR_Budget_1_4-1.4.pdf
322943 RR_SubawardBudget30_1_4-1.4.pdf
322943 PHS398_ModularBudget_1_2-1.2.pdf
322943 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
322943 RR_SF424_2_0-2.0.pdf
322943 PHS398_CoverPageSupplement_5_0-5.0.pdf
322943 RR_OtherProjectInfo_1_4-1.4.pdf
322943 PerformanceSite_2_0-2.0.pdf
322943 RR_KeyPersonExpanded_2_0-2.0.pdf
322943 PHS398_ResearchPlan_4_0-4.0.pdf
322943 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
322943 RR_Budget_1_4-1.4.pdf
322943 RR_SubawardBudget30_1_4-1.4.pdf
322943 PHS398_ModularBudget_1_2-1.2.pdf
322943 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
